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During the last years there has been increasing
interest in the investigation of biochemical para-
meters which in addition to placental steroids and
peptide hormones might be indicators of placen-
tal function and fetal well-being. In this paper we
present data on the pregnancy-specific ßi -glyco-
protein S?! and tiy to evaluate its clinical signi-
ficance.
SPj was isolated and characterized by BOHN [l,
2]. TATARINOV reported on comparative immu-
nodiffusion investigations which showed identity
of his pregnancy specific ß-globulin [20, 21] andof
PAPP-C of LIN et al. [9] with pregnancy-specific
ßi -glycoprotein (SPi).
SPj was characterized äs a ßl -glycoprotein with a
carbohydrate content of 29% and a molecular
weight of 90000-110000 [3, 9]. Recently the
occurrence of a high molecular weight variant was
proposed [25]. The protein is synthesized in the
syncytiotrophoblast of the placenta [8, 18] and
secreted into the maternal blood in increasing con-
centrations äs pregnancy proceeds [5,6,16,21,29,
31]. Its detection is possible äs early äs 18 days
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after ovulation and hence has been recommended
äs pregnancy test [6]. The biological function is
still unknown. Actually SP1 is not truly pregnancy-
specific. Trace amounts have been detected in
nonpregnant individuals [30] and in cultured
fibroblasts [13]. Elevated serum levels can arise
in patients with trophoblastic and non-tropho-
blastic malignancies [7, 14,15, 20,30].
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l Materials and methods
1.1 Blood samples were taken from healthy
pr gnant women and from hospitalized and out-
patients. Amniotic fluid was obtained from amnio-
centeses (performed under ultrasonic control) and
from deliveries.
l .2 Radioiodination of SPi
5 g of S?! purified from placenta [4] in 10 μΐ of
phosphate buffered saline were mixed with 0.5 m
Ci lodide in 10 μΐ of a 125-J-Na-solution (Behring-
werke AG, Marburg, FRG; 8-15 Ci 125 J per mg
J) and with a Suspension of l Mg Lactoperoxidase
(B.C. 1.11.1.7, BOEHRINGER, Mannheim, FRG)
in 10 μΐ PBS. H2O2 in 30% solution was used at a
1:10 000 dilution in PBS and 10 μΐ were added in
portions of l μΐ per minute. After a further 10 min.
of stirring at room temp. the reaction was stopped
by 0.2 ml of 1% NaN3 in PBS containing 1% bo-
vine serum albumine. The labeled SPt was purified
by gel Filtration on Sephadex G 75 (PHARMACIA,
Uppsala, Sweden) and contained approximately
l .3 Radioimmunoassay of SPj
0.1 ml of serum at dilutions of 1:1000 to 1:5000
in PBS plus 1% BSA, 0.2 ml with 0.1 ng of labeled
SPj and 0.2 ml of monospecific antiserum (from
rabbit, Charge No. 5756, d uted 1:250.000) were
incubated at room temp. for 24-48 ho rs. Precipi-
tation was achieved by the addition of 0.1 ml of
0.25 % rabbit serum and 0.1 ml of l: 16 d uted anti-
rabbitserum from donkey (WELCOME Labora-
tories Beckenham, England), incubation for 18
hours at 4 °C and centrifugation for 30 min at
3000 X g. Serum samples were assayed in dupli-
cates, samples of amniotic fluid (du. 1:50) in tri-
plicates.
l .4 Radioimmunoassay of HPL
The determination of human placental lactogen in
serum was performed with the radioimmunoassay-
kit from AMERSHAM BUCHLER (Braunschweig,
FRG).
1.5 Determination of SPj
diffusion
by radial immuno-
After the 20th gestational week "M-Pargiten-
Plates" (OTCE, BEHRINGWERKE) and in early
pregnancy especially prepared "Low Capacity
Plates" (No. 3551, BEHRINGWERKE) were applied.
Lyophylized SPj, reference sample (OTFL, BEH-
RINGWERKE) was used s a Standard.
2 Results
2.1 Standard curve
The highly sensitive radioimmunoassay, preve-
ously described [30], permits the determination
of 8Ρχ in concentrations from 2 to 200 ng/ml
(Fig. 1). The interassay-Variation was below 10%.
Conceming the specificity, no cross-reaction was
observed with HPL, HCG, prolactin or FSH and
LH (not depicted in Fig. 1). The immunologic
identity of placental SPi (Standard) and serum
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Fig. 1. Standard dose response curve for SPi. · = Purified
SPi from placenta, · = Serial dilutions of a late pregnancy
serum.
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2.2 Normal ränge
335 single values were assayed from 227 pregnant
women from week 3 to 41 of pregnancies which
were retrospectively judged to be normal. Fig. 2
shows these single values and a "moving median"
(calculated by considering 5 weeks of pregnancy
for each time point) and the lOth and 90th per-
centile. The median concentration rose continu-
ously up to 140 Mg/ml in week 36, when a plateau
seemed to be formed. A widespread distribution
of normal values was then found between 80 and
240 Mg/ml. S?i concentrations in serial controls of
three singleton pregnancies and one twin pregn-
ancy are compared in Fig. 3 by radioimmuno-
assay and radial immuno-diffusion [11]. With the
latter method usually higher concentration values
were obtained. The course of the curves was in
rather good agreement.
2.3 Complicated eaiiy pregnancies
The serum SPj concentrations of patients who
were admitted to the hospital because of vaginal
bleeding are shown in Fig. 4. In this group 73 cases
with threatened abortion and continuation of
pregnancy, 6 cases of progredient abortion, 5
cases of habitual abortion and 5 cases with sub-
sequent fetal death were evenly distributed within
the normal ränge. Only the group of patients with
incomplete abortion exhibited markedly reduced
SPi levels. 44% of the assay values were below the
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Fig. 2. SPi concentrations in maternal plasma in normal pregnancies. (The curves represent the median, the lOth and
90th percentile).
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Füg. 3. Serial controls of SPi levels in normal pregnancies. (Curves 1,2,3 = singleton pregnancies, curve 4 = twins). The





Fig. 4. Serum concentrations of SPi in° cases of vaginal bleeding in early pregnancy. Single assay values are plotted
against the normal ränge. Threatened abortion with continued pregnaney, · = progredient abortion, * = habitual
abortion, · incomplete abortion, ® = subsequent fetal death.
Würz et al., SPi in normal and pathologic pregnancies 71
tients with hyperremesis were analyzed between
the 8th and 17th week, 12 assay values were found
above the 90% confidence limit, 15 within the
normal ränge and one below the 10% confidence
limit.
2.4 Rhesus incompatibility
In serial controls of five patients with Rh-incom-
patibility the S?i values were distributed within
the normal ränge. All the babies were delivered
after the 38th week of pregnancy and exhflnted
only a mild form of erythroblastosis.
steeply increase during the last trimester and all
of them showed a marked decline at the time
when the termination of the pregnancy was indi-
cated by other clinical parameters. The drop of
SPi in case No. 6 was associated with fetal death.
These changes in concentration concerned only
S?i. HPL and the estrogens remained within
their normal ranges. 34 additional samples from
24 individuals were assayed. 17 (50%) were found
within the normal ränge, 3 (9%) above and 14
(41%) below the confidence limits. The trend to-
wards lower values was predominant in the last
weeks of pregnancy.
2.5 Diabetes
In Fig. 5 the follow-ups of six pregnancies compli-
cated by insulin-dependent diabetes are described.






In our collective of pathologic pregnancies we
encountered seven stillbom children. In all cases
the S?i level in the maternal blood was below the
mean value, in one case below the lOth percentile.
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2.7 Premature labor
Serial controls of SPi and HPL levels were per-
formed in 14 patients being treated with j3-mimetic
drugs. Before and during treatment the 8Ρχ values
were consitently below the lOth percentile in six
cases (two with "small-for-date-babies") and be-
tween the lOth percentile and the median in seven
patients. The corresponding HPL-values were be-
low the lOth percentile only in the two cases with
fetal retardation. The other follow-up curves were
evenly distributed within the normal r nge.
2.8 Fetal growth retardation
A total of 86 plasma samples from 58 individuals
was analyzed in risk pregnancies which led to
"small-for-date" babies (Fig. 6). Growth retarda-
tion was estimated according to the classification
of LUBCHENKO et al. [10]. A marked tendency
towards reduced S?! values was noted: 85%of all
cases were found below tKer median and 45%
below the lOth percentile. No differences could
be observed between cases with or without the
Symptoms of dystrophy.
2.9 Gestosis
The data in Fig. 7 were obtained from pregnancies
complicated by gestosis in the third trimester.
They were devided into A: cases, in which only
one or two of the Symptoms hypertension, edema
and proteinuria were present and B: trisympto-
matic forms of EPH-gestosis. Many of these were
associated with fetal growth retardation. A con-







Fig. 6. Concentrations of SPi in maternal plasma in pregnancies with "small-for-date" babies (· = with, o = without
signs of dystrophy).
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Fig. 7. Serum SPi concentrations in casesof EPH-gestosis
with one or two (o) and three Symptoms (o) äs plotted
against the normal ränge. The dotted line represents the
median of the assay values in the whole collective of
gestosis patients.
A: 55cases B: 71 cases
Below the median: 44 (80%) 60 (85%)
Belowthelothpercentile: 22(40%) 27(38%)
Additionally we compared serial controls of S?i
and HPL (Fig. 8a and 8b) from 14 patients with
EPH-gestosis. Curves l, 2, 3,4 and 9 represent the
condition of toxemia associated with fetal growth
retardation. Case 9 was terminated by fetal death.
Many courses of the follow-ups of HPL and SPi
resemble each other although they are located at
different levels of the appropriate normal ränge.
So, curves 2, 6 and 10 give the impression of a
normal pregnancy äs far äs HPL is concemed
while the SPi concentrations are partially below
the 10% confidence limit. In cases l, 12 and 8 the
conditions are vice versa.
2.10 Analysis of amniotic fluid
The distribution ofSPi concentrations in amniotic
fluid during normal pregnancies from week 13 to
term is shown in Fig. 9. The mean values and 90%
confidence limits are indicated up to the 20th
gestational week. Thereafter the small number of
samples available allowed only for a rough estima-
tion of the normal ränge. The S?i levels increased
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Fig. 8. Serial controls of serum SPi (a) and HPL (b)
from 14 patients with EPH-gestosis. Assay values are
plotted against the normal ranges of SPi and HPL. Curves
l, 2, 3, 4 represent cases of gestosis associated with fetal
growth retardation. Curve 9 = fetal death).
sented approximately 1% of the serum concentra-
tions. In Fig. 10 amniotic fluid samples of ab-
normal conditions are compared with the normal
Status. From 16 women with RH-incompatibility
four exhibited values above and two below the
normal ränge. One serial control curve l started
with strikingly high values in the 24th week and
feil into the upper normal ränge after week 35.
Since the newbom was RH-negative (Anti-D titer
1:32) the incompatibility was of no clinical signi-
ficance. Curve 2 which is situated within the nor-
mal ränge stems from a patient who developed an
J.Perinat. Med. 2(1981)
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10. SPi in amniotic fluid in abnormal pregnancies.
Rhesus incompatibility, o = twins, * = trisomy 21,
congenital mesoblastic nephroma.
anti-D titer of 1:512 and was delivered from a RH-
positive child with erhythroblastosis. Curve 3 re-
presents the S?i values of a case with the rare dia-
gnosis of a congenital mesoblastic nephroma
which was terminated by fetal death? Fetal mpn-
golism was (in 9 from 12 cases) associated with
SPi concentrations below the mean value. So were
t wo cases of trisomy 18 and onö of trisomy 13
(not depicted in Fig. 10). In five twin-pregnancies
SPi was in the upper normal ränge. Seven gono-
somal anomalies were in the normal ränge, one
was below the loth percentile. T wo cases of
hydramnios showed elevated levels. From five
cases of anencephaly two were above, pne below
and two within the normal ränge.
3 Discussion
With the radioimmunoassay described the SPi dis-
tribution curve of a normal collective of pregnant
women was established. The median line inereased
from 3 Mg/ml in the 8th gestational week to 140
Mg/ml in the 38th week. Several surprisingly low
J. Perihat. Med. 2 (1981)
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levels have been found in the serum of healthy
mothers with newboms of normal birthweight.
Occasionally veiy low values were reported by
other authors [24, 26] who explained them by
the presence of a high molecular weight variant
of S?i, which is not detected by the radioimmuno-
logical method which we used.
For the first time the distribution of SPi in am-
niotic fluid was determined throughout normal
pregnancies. Concentrations of about 1% of the
respective serum value were in agreement with
single assay values in this magnitude reported pre-
viously [22,28]. Because of the limited number of
samples so far analyzed the limits of the normal
ränge in amniotic fluid could not be determined
with accuracy. Out of all the abnormal pregnancies
investigated only the cases with trisomies 21, 18
and 13 showed a tendency towards low concentra-
tions. The possible explanation could be a placen-
tal distrophy which is frequently associated with
fetal mongolism. All twin pregnancies were found
above the median, which might be explained by
the enlarged placental mass. SPj concentrations in
gonosomal anomalies and anencephaly are not of
predictive value. The SJ?i concentrations in cases of
RH-incompatibility were scattered around and
within the normal ränge and cannot assist in the
assessment of this disorder. The same holds for the
plasma levels in RH-sensitized mothers.
In maternal serum the normal distribution was
compared with a variety of pregnancy complica-
tions which more or less modified the SPi levels.
In early pregnancy the SPj concentrations were
reduced in cases of abortions. In this paper we
report only on single assay values. Although
these already indicate the pathologic condition,
serial controls should be carried out routinely.
SCHULTZ-LARSEN et al. [17] have demonstrated
the high predictive value of S?i for the outcome
of pregnancy in cases of threatened abortion. We
found, however, cases of progredient abortion also
within the normal ränge. In patients with prema-
ture labour low S?i concentrations were detected
in contrast to normal HPL values, a fact which äs
yet cannot be interpreted. S?! apparently cor-
relates with fetal size. Intrauterine growth retar-
dation led to reduced concentrations in most
pregnancies with small-for-date babies. No diffe-
rentiation, however, was possible between children
with or without signs of malnutrition and thus the
SPi values seem to reflect the placental function
better than the condition of the newborn. In
follow-ups of patients with EPH-gestosis a marked
tendency towards low SPi levels was observed.
A comparison with human placental lactogen
revealed the equal qualities of these two para-
meters or even the superiority of SP1 in several
cases. These findings are consistent with analogous
studies of other investigators [12, 23, 27] and sug-
gest the clinical usefulnes of 8 determinations äs
an additional indicator in the monitoring of high
risk pregnancies.
Summary
SPi, the pregnancy-specific ßi-glycoprotein, was studied
in normal and pathologic pregnancies. We developed a ;
highly specific and sensitive double-antibody-radioim-
munoassay by radioiodination of purified placental SPi-
This RIA allowed the estimation of SPi concentrations äs
low äs 2 ng/mL In a coüective of 227 women with normal
pregnancies we established the normal distribution curve
in maternal plasma from the fifth week of gestation to
term. The median value rose $teadily from 3 Mg/ml in the
8th week to 140 Mg/ml in the 36th week when a plateau
was iormed.
In more than 400 patients with pregnancies complicated
by a variety of pathologic disorders the SPi levels were
controlled by either single assays or serial estimations
throughout pregnancy and were compared with the
normal distribution ränge. SPi was also determined in
about 200 samples of amniotic fluid gained by amnio-
centesis and during parturition of normal pregnant
women from the 13th gestational week until term. The
normal ränge was established up to the 20th w.o.p. The
concentrations rose from below 0.2 Mg/ml in early preg-
nancy to 3 Mg/ml and generally amounted to approxi-
mately l % of the respective serum value. Pathologic cases
with diverse chromosomal anomalies, Rh-incompatibility,
anencephaly, hydramnios and other abnormal conditions
were examined. From these only twin-pregnancies with
slightly elevated levels and cases with fetal trisomies with
reduced SPj concentrations showed aberrations from the
normal distribution. The estimation of serum concentra-
tions in mothers with diabetes or Rh-incompatibility were
J. Perinat. Med. 2(1981)
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not significantly different from the normal collective. In
diabetes a characteristic course of the follow-up curves
was observed.
Abortion in early pregnancy was frequently but not al-
ways indicated by reduced SPi values. Threatened abor-
tion with subsequent continuation of pregnancy exhibited
SPi values scattered within the normal ränge. Since the
radioimmunological determination of SPi is possible in
the early stage of gestation (from week 8) it may serve äs
a useful tool for prediction at times when the determina-
tion of placental lactogen is not yet possible. In pregnan-
äes with "small-for-date babies" the correlation between
SPi in maternal plasma and fetal growth retardation was
reflected in a pronounced tendency to low SPi levels.
Serial determinations of SPi in the serum of women
with EPH-gestosis were compared with the corresponding
HPL determinations and showed theequality of SPi con-
cerning the assessment of the placental function.
Keywords: Abortion, amniotic fluid, chromosomal anomalies, pathologic pregnancies, placental function, pregnancy
specific ßj-glycoprotein, radioimmunoassay, small for date babies, SPi, twin pregnancies.
Zusammenfassung
Radioimmunoassay für SPi (Schwangerschaftsspezifisches
0i-Glykoprotein) im mütterlichen Blut und im Frucht-
wasser während normaler und pathologischer Schwanger-
schaften
SP\, das schwangerschaftsspezifische ßi-Glykoprotein,
wurde in normalen und pathologischen Schwangerschaf-
ten mit einem hochspezifischen und sensitiven Doppel-
an tikörper-Radioimmunoassay untersucht. Die Empfind-
lichkeit der Methode liegt bei 2 ng/ml. Aus einem Kollek-
tiv von 227 normalen Schwangerschaften mit 335 Einzel-
werten konnte eine Normkurve mit Standardabweichun-
gen von der 5. bis zur 40. SSW errechnet werden. Der
Medianwert zeigt einen kontinuierlichen Anstieg von
3 Mg/ml in der 8. Woche bis 140 Mg/ml in der 36. Woche,
wonach die Kurve in Form eines Plateaus bis zum Schwan-
gerschaftsende verläuft. Aus 200 Einzelproben von Frucht-
wasser, welches durch Amniozentese ab der 13.Wocheoder
im Laufe der Geburt nach Blasensprengung gewonnen
wurde, konnte auch für die SPi-Konzentration im Frucht-
wasser ein Normbereich von der 13. bis zur 20. Schwanger-
schaftswoche erstellt und für den weiteren Verlauf ge-
schätzt werden. Es zeigte sich ein Anstieg von 0.2 Mg/ml
bis 3 Mg/ml, was einer relativen Konzentration von l % der
korrespondierenden Serumwerte entspricht. An patho-
logischen Schwangerschaftsverläufen wurden diverse
Chromosomenanomalien, RH-Inkompatibüität, Anenze-
phalie, Hydramnion und andere untersucht. Auffallende
Abweichungen von der Norm wiesen nur Zwillingsschwän^
gerschaften mit leicht erhöhten Werten und Trisomien
mit eindeutig erniedrigten SPj-Konzentrationen auf.
Im Serum wurden Einzelwerte oder Verlaufsbeobachtun-
gen der SP i-Konzentrationswerte bei über 400 Patien-
tinnen mit unterschiedlichen pathologischen Schwanger-
schaftsverläufen mit dem Normkollektiv verglichen. Die
SPi-Serumkonzentrationen von Müttern mit Diabetes
oder RH-Inkompatibilität unterscheiden sich vom Norm-
kollektiv nicht. Auffällig ist allerdings ein präpartualer
Abfall der Verlaufskurven bei Diabetes-Patientinnen. Bei
Blutungen in der Frühschwangerschaft (Abortus immi-
nens) streuen die Fälle mit Fortbestand der Schwanger-
schaft innerhalb des Normbereiches, während bei späte-
rem Abort die Einzelwerte meist stark erniedrigt sind.
SPi scheint ein geeigneter Parameter für die Prognose der
Frühschwangerschaft zu sein und ist hier dem HPL wegen
seiner früheren Nachweisbarkeit überlegen. In Schwanger-
schaften mit "small-for-date-babies" zeigt sich eine Kor-
relation zwischen der SPi-Konzentration im mütter-
lichen Serum und der fetalen Retardierung. Serienbestim-
mungen von SPi im Serum von Frauen mit schwerer
Gestose wurden mit den korrepondierenäen HPL-Werten
verglichen und ergaben die Gleichwertigkeit des SPi als
Parameter der Plazentafunktion.
Schlüsselwörter: Abort, Chromosomenanomalien, Fruchtwasser, kindliche Wachstumsretardierung, pathologische
Schwangerschaftsverläufe, Plazentafunktion, Radioimmunoassay, Schwangerschaftsspezifisehes 0 -
Glycoprotein (SPi), Zwillingsschwangerschaften.
Resume
Dosage radioimmunologique de SPi (proteine speci-
fique de grossesse) dans le sang maternel et dans le liquide
amniotique dans les grossesses normales et pathologiques
A l'aide d'un anticorps double hautement specifique et
sensible nous avons dose radioimmunologiquement la
SPi, la proteine specifique de grossesse, au cours de
grossesses normales et pathologiques. La precision de la
methode est de 2 ng/ml. A partir d'un collectif de 227
grossesses normales avec 335 valeurs individuelles nous
avons trace une courve de normalite avec les deviations
Standart de la Seme a la 40eme semaines de grossesse. La
valeur moyenne montre une augmentation continue de
3 Mg/ml a la Seme semaine a 140 Mg/ml dans la 36eme
semaine apres quoi la courbe stagne sur un plateau jus-
J. Perinat. Med. 2 (1981)
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qu'en fin de grosscsse. A partir de 200 plelevements de
liquide amniotique que nous avons obtenus a partir de la
13eme semaine par amniocentesc ou bien pcndant l'ac-
couchcment apres Pamniotomie, nous avons pu obtenir
la courbe de la concentration normale de SPi dans le
liquide amniotique entre la l Seme et la 20eme semaines
et faire une estimation quant a son evolution ultcrieure.
Nous avons observe une augmentation de 0,2 Mg/ml
jusqu'ä 3 Mg/ml ce^ qui correspond approximativement
a 1% des valeurs seriques correspondantes. Au cours de
grossesscs pathologiques nous avons examine diverses
anomalies chromosomiques, des incompatibilites Rhesus,
l'anacephalie, Thydramnios etc. Les deviations notables
de la norme son t observecs seulement dans les grossesses
gemellaires, avec des valeurs legerement augmentees et
les trisomie, avec des concentrations de SPi franchement
basses.
Des valeurs individuelles seriques ou bien des observations
cvolutives des valeurs de S?l sur plus de 400 grossesses
avec des devenirs pathologiques varies ont etc comparecs
avec les valeurs normales. II n'y a pas de differences pour
les valeurs de SPi chez les meres diabetiques et les incom-
patibiles Rhesus. Nous avons cepandant observe une chute
prepartale des eourbes chez les diabetiques. En cas de
saignements en debut de grossesse (menace d'avortement
spontane) les valeurs des grossessscs qui continuent sont
dispersees dans la zone de normalste, alors que lorsque la
grossesse doit avorter plus tard, les valeurs individuelles
sont generalement fortement diminuees. La SPi semble
etre un parametre approprie pour le pronostic de la gross-
esse debutante est s'avere ici etre supericur a la HPL du
fait de sä detection plus precoce. Au cours des grosscsse
aboutissant a des hypotrophes il existe une correlation
entre la concentration serique matemelle de SPj et le
dcgre d'hypotrophie. Nous avons realise des determina-
tions en serie de SPi dans le serum de femme avec une
toxemie scvcre et les avons comparecs aux valeurs de HPL
correspondantes; elles ont montre le caractere identiquc
des deux methodes quant a l'appreciation de la function
placcntaire.
Mots-cles: Dosage radioimmunologique, evolution pathologique de la grossesse, fausse-couche, anomalies chromoso-
miques, fonction placcntaire, grossesses gemellaires, liquide amniotique, proteine ßi specifique de grossesse
(SPi), retard de croissance intrauterin.
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